Vanta Bioscience Ltd - 540729 - Update on board meeting
The Board Meeting to be held on 23/06/2021 has been revised to 28/06/2021 The Board Meeting to be held on 23/06/2021 has been revised to 28/06/202122-06-2021
22-06-2021
Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Audited Financial Statements Of The Company For The Half Year And Year Ended March 31, 2021 And Raising Of Capital Through Preferential Allotment Of Equity Shares
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/06/2021 ,inter alia, to consider and approve 1. The standalone and consolidated audited financial statements of the Company for the half year and year ended March 31, 2021. 2. Raising of capital through preferential allotment of equity shares subject to the requisite approvals from shareholders and BSE Ltd. This is for your information17-06-2021
Vanta Bioscience Ltd - 540729 - Intimation Regarding Application Filed Against The Company Before NCLT Under Section 9 Of Insolvency And Bankruptcy Code, 2016
Intimation regarding application filed against the Company before NCLT under section 9 of Insolvency and Bankruptcy Code, 201615-06-2021
Vanta Bioscience Ltd - 540729 - Vayam Research Solutions Limited Ceases To Be A Step Down Subsidiary Of The Company
Vayam Research Solutions Limited ceases to be a step down subsidiary of the Company22-05-2021
Vanta Bioscience Ltd - 540729 - Compliance Certificate Under Regulation 40(9) For Half Year Ended March 31, 2021
Compliance Certificate under Regulation 40(9) for half year ended March 31, 202121-04-2021
Vanta Bioscience Ltd - 540729 - Compliance Certificate Under Regulation 7(3) For The Half Year Ended 31.03.2021
Compliance Certificate under Regulation 7(3) for the half year ended 31.03.202121-04-2021
Vanta Bioscience Ltd - 540729 - Shareholding for the Period Ended March 31, 2021
Vanta Bioscience Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here20-04-2021
Vanta Bioscience Ltd - 540729 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Zoheb SayaniDesignation :- Company Secretary and Compliance Officer14-04-2021
Vanta Bioscience Ltd - 540729 - Grant Of Registration By DCGI To Vayam Research Solutions Limited, Step Down Subsidiary Of Vanta Bioscience Limited
We are happy to inform that Vayam Research Solutions Limited ('Vayam'), a step down subsidiary of Vanta Bioscience Limited has received a registration certificate from Drugs Controller General (India) ('DCGI') for its workshop at Gandhi Nagar, Gujarat to conduct bioavailability and bioequivalence studies of new drugs and investigational new drugs as specified in the New Drugs and Clinical Trial Rules, 2019.12-04-2021
Vanta Bioscience Ltd - 540729 - Closure of Trading Window
The trading window for transactions in shares of the Company for all designated persons and their immediate relatives will be closed from April 01, 2021 till the 48 hours after the declaration of audited financial results of the Company for the half year and year ended March 31, 2021. The date of Board Meeting for consideration of audited financial results of the Company for the half year and year ended March 31, 2021 shall be intimated in due course of time31-03-2021